Pharmacokinetics of carfilzomib in patients with advanced malignancies and varying degrees of hepatic impairment: an open-label, single-arm, phase 1 study

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2162-3619

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Pharmacokinetics of carfilzomib in patients with advanced malignancies and varying degrees of hepatic impairment: an open-label, single-arm, phase 1 study ; volume:6 ; number:1 ; day:3 ; month:10 ; year:2017 ; pages:1-12 ; date:12.2017
Experimental hematology & oncology ; 6, Heft 1 (3.10.2017), 1-12, 12.2017

Keyword: Krebs
Onkologie

Creator: Brown, Jennifer

Contributor: Plummer, Ruth
Bauer, Todd M.
Anthony, Stephen
Sarantopoulos, John
Vos, Filip De
White, Mike
Schupp, Marco
Ou, Ying
Vaishampayan, Ulka
SpringerLink (Online service)

DOI: 10.1186/s40164-017-0086-1

URN: urn:nbn:de:1111-201711273078

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:27 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Brown, Jennifer
Plummer, Ruth
Bauer, Todd M.
Anthony, Stephen
Sarantopoulos, John
Vos, Filip De
White, Mike
Schupp, Marco
Ou, Ying
Vaishampayan, Ulka
SpringerLink (Online service)

Other Objects (12)

Pharmacokinetics and safety of brivaracetam in neonates with repeated electroencephalographic seizures : : a multicenter, open‐label, single‐arm study

Safety and pharmacokinetics of imaradenant (AZD4635) in Japanese patients with advanced solid malignancies: a phase I, open-label study

Safety, tolerability, pharmacokinetics, and antitumour activity of oleclumab in Japanese patients with advanced solid malignancies: a phase I, open-label study

A Multi‑Center, Open‑Label, Single‑Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency

Pharmacokinetics and safety of carfilzomib in patients with relapsed multiple myeloma and end-stage renal disease (ESRD): an open-label, single-arm, phase I study

Pembrolizumab in advanced osteosarcoma: results of a single-arm, open-label, phase 2 trial

Effect of Varying Degrees of Renal Impairment on the Pharmacokinetics of Omecamtiv Mecarbil

Correction to: A Multi-center, Open-Label, Single-Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency

Population Pharmacokinetics of Blinatumomab in Pediatric and Adult Patients with Hematological Malignancies

Gene replacement therapy in Bietti crystalline corneoretinal dystrophy: an open-label, single-arm, exploratory trial

Efficacy and safety of minocycline in retinitis pigmentosa: a prospective, open-label, single-arm trial

Erdafitinib in Asian patients with advanced solid tumors: an open-label, single-arm, phase IIa trial

Pharmacokinetics and safety of brivaracetam in neonates with repeated electroencephalographic seizures : : a multicenter, open‐label, single‐arm study

Safety and pharmacokinetics of imaradenant (AZD4635) in Japanese patients with advanced solid malignancies: a phase I, open-label study

Safety, tolerability, pharmacokinetics, and antitumour activity of oleclumab in Japanese patients with advanced solid malignancies: a phase I, open-label study

A Multi‑Center, Open‑Label, Single‑Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency

Pharmacokinetics and safety of carfilzomib in patients with relapsed multiple myeloma and end-stage renal disease (ESRD): an open-label, single-arm, phase I study

Pembrolizumab in advanced osteosarcoma: results of a single-arm, open-label, phase 2 trial

Effect of Varying Degrees of Renal Impairment on the Pharmacokinetics of Omecamtiv Mecarbil

Correction to: A Multi-center, Open-Label, Single-Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency

Population Pharmacokinetics of Blinatumomab in Pediatric and Adult Patients with Hematological Malignancies

Gene replacement therapy in Bietti crystalline corneoretinal dystrophy: an open-label, single-arm, exploratory trial

Efficacy and safety of minocycline in retinitis pigmentosa: a prospective, open-label, single-arm trial

Erdafitinib in Asian patients with advanced solid tumors: an open-label, single-arm, phase IIa trial

Pharmacokinetics and safety of brivaracetam in neonates with repeated electroencephalographic seizures : : a multicenter, open‐label, single‐arm study

Safety and pharmacokinetics of imaradenant (AZD4635) in Japanese patients with advanced solid malignancies: a phase I, open-label study

Safety, tolerability, pharmacokinetics, and antitumour activity of oleclumab in Japanese patients with advanced solid malignancies: a phase I, open-label study

A Multi‑Center, Open‑Label, Single‑Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency

Pharmacokinetics and safety of carfilzomib in patients with relapsed multiple myeloma and end-stage renal disease (ESRD): an open-label, single-arm, phase I study

Pembrolizumab in advanced osteosarcoma: results of a single-arm, open-label, phase 2 trial

Effect of Varying Degrees of Renal Impairment on the Pharmacokinetics of Omecamtiv Mecarbil

Correction to: A Multi-center, Open-Label, Single-Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency

Population Pharmacokinetics of Blinatumomab in Pediatric and Adult Patients with Hematological Malignancies

Gene replacement therapy in Bietti crystalline corneoretinal dystrophy: an open-label, single-arm, exploratory trial

Efficacy and safety of minocycline in retinitis pigmentosa: a prospective, open-label, single-arm trial

Erdafitinib in Asian patients with advanced solid tumors: an open-label, single-arm, phase IIa trial

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Pharmacokinetics of carfilzomib in patients with advanced malignancies and varying degrees of hepatic impairment: an open-label, single-arm, phase 1 study

Object Details

References and Relationships

Classification and Topics

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Pharmacokinetics and safety of brivaracetam in neonates with repeated electroencephalographic seizures : : a multicenter, open‐label, single‐arm study

Safety and pharmacokinetics of imaradenant (AZD4635) in Japanese patients with advanced solid malignancies: a phase I, open-label study

Safety, tolerability, pharmacokinetics, and antitumour activity of oleclumab in Japanese patients with advanced solid malignancies: a phase I, open-label study

A Multi‑Center, Open‑Label, Single‑Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency

Pharmacokinetics and safety of carfilzomib in patients with relapsed multiple myeloma and end-stage renal disease (ESRD): an open-label, single-arm, phase I study

Pembrolizumab in advanced osteosarcoma: results of a single-arm, open-label, phase 2 trial

Effect of Varying Degrees of Renal Impairment on the Pharmacokinetics of Omecamtiv Mecarbil

Correction to: A Multi-center, Open-Label, Single-Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency

Population Pharmacokinetics of Blinatumomab in Pediatric and Adult Patients with Hematological Malignancies

Gene replacement therapy in Bietti crystalline corneoretinal dystrophy: an open-label, single-arm, exploratory trial

Efficacy and safety of minocycline in retinitis pigmentosa: a prospective, open-label, single-arm trial

Erdafitinib in Asian patients with advanced solid tumors: an open-label, single-arm, phase IIa trial

Pharmacokinetics and safety of brivaracetam in neonates with repeated electroencephalographic seizures : : a multicenter, open‐label, single‐arm study

Safety and pharmacokinetics of imaradenant (AZD4635) in Japanese patients with advanced solid malignancies: a phase I, open-label study

Safety, tolerability, pharmacokinetics, and antitumour activity of oleclumab in Japanese patients with advanced solid malignancies: a phase I, open-label study

A Multi‑Center, Open‑Label, Single‑Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency

Pharmacokinetics and safety of carfilzomib in patients with relapsed multiple myeloma and end-stage renal disease (ESRD): an open-label, single-arm, phase I study

Pembrolizumab in advanced osteosarcoma: results of a single-arm, open-label, phase 2 trial

Effect of Varying Degrees of Renal Impairment on the Pharmacokinetics of Omecamtiv Mecarbil

Correction to: A Multi-center, Open-Label, Single-Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency

Population Pharmacokinetics of Blinatumomab in Pediatric and Adult Patients with Hematological Malignancies

Gene replacement therapy in Bietti crystalline corneoretinal dystrophy: an open-label, single-arm, exploratory trial

Efficacy and safety of minocycline in retinitis pigmentosa: a prospective, open-label, single-arm trial

Erdafitinib in Asian patients with advanced solid tumors: an open-label, single-arm, phase IIa trial

Pharmacokinetics and safety of brivaracetam in neonates with repeated electroencephalographic seizures : : a multicenter, open‐label, single‐arm study

Safety and pharmacokinetics of imaradenant (AZD4635) in Japanese patients with advanced solid malignancies: a phase I, open-label study

Safety, tolerability, pharmacokinetics, and antitumour activity of oleclumab in Japanese patients with advanced solid malignancies: a phase I, open-label study

A Multi‑Center, Open‑Label, Single‑Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency

Pharmacokinetics and safety of carfilzomib in patients with relapsed multiple myeloma and end-stage renal disease (ESRD): an open-label, single-arm, phase I study

Pembrolizumab in advanced osteosarcoma: results of a single-arm, open-label, phase 2 trial

Effect of Varying Degrees of Renal Impairment on the Pharmacokinetics of Omecamtiv Mecarbil

Correction to: A Multi-center, Open-Label, Single-Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency

Population Pharmacokinetics of Blinatumomab in Pediatric and Adult Patients with Hematological Malignancies

Gene replacement therapy in Bietti crystalline corneoretinal dystrophy: an open-label, single-arm, exploratory trial

Efficacy and safety of minocycline in retinitis pigmentosa: a prospective, open-label, single-arm trial

Erdafitinib in Asian patients with advanced solid tumors: an open-label, single-arm, phase IIa trial

Related objects

Reset password